Facebook
X
LinkedIn
Forward2025 Endocrinology Grand Rounds | Endocrinology-disrupting Chemicals
There is still a lot to learn about Endocrine-disruptive Chemicals (EDC) impact on health. EDCs don't have large-scale trials, data is often obtained from epidemiological studies or animal models, which some clinicians find less convincing. EDCs are found in everyday products—plastics, cosmetics, pesticides, food packaging, and more. Since endocrinologists diagnose and treat hormone-related disorders, understanding how EDCs affect these systems is essential.
EDCs can mimic, block, or alter hormone signals, leading to disruptions in processes like growth, metabolism, reproduction, and mood regulation. The Endocrine Society has emphasized the importance of EDCs in public health. Noting their potential role in chronic diseases like diabetes, obesity, and hormone-sensitive cancers. Asking targeted questions about lifestyle, occupation, and product use could help to evaluate potential EDC exposure. It is imperative to create awareness and increase interest in public health and environmental toxins and their impact on Endocrinology care.
Target Audience
Physicians, endocrinologists, clinical staff and all other healthcare professionals interested in the subject matter.
Learning Objectives
- Outline the impacts of Endocrine-disruptive Chemicals (EDC).
- Identify gaps in data and confounding factors.
- Discuss potential research opportunities.
- Implement new knowledge into patient care.
Additional Information
| Attachment | Size |
|---|---|
 AB 1195 & AB 241 Biblio | 204.58 KB |
Virtual Meeting- Zoom
Michael. H. Shannon, MD Endocrinologist, Summit Pacific Medical Center; Clinical Assistant Professor, University of Washington
Presenter: Dr. Shannon has indicated the following relevant financial relationships: On the Speakers Bureau for Bayer and Novo Nordisk; Consultant for Bayer.
Planner: Pooja Manroa, MD has indicated that there are no relevant financial relationships with ineligible companies.
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2025 Endocrinology Grand Rounds | Endocrinology-disrupting Chemicals for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance